agence nationale de recherches sur le sida
epidemiologie clinique du sida en aquitaine
validated high-performance liquid chromatography method
usc*pack pc clinical programs
french drug agency temporary authorization
previously established pi mutations enables
nonnucleoside hiv-1 reverse transcriptase inhibitor
monitor individual lpv plasma concentrations
low plasma lpv concentrations favored
human immunodeficiency virus type 1 genotypic
